☆ 4.4 Letter

Treatment of Refractory Chronic Pruritus of Unknown Origin With Tofacitinib in Patients With Rheumatoid Arthritis

JAMA DERMATOLOGY (2019)

Get Full Text
Add to Collection

Journal

JAMA DERMATOLOGY
Volume 155, Issue 12, Pages 1426-1428

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamadermatol.2019.2804

Keywords

-

Categories

Dermatology

Funding

  1. Doris Duke Charitable Foundation
  2. Celgene Corporation
  3. LEO Pharma
  4. National Institute of Arthritis Musculoskeletal and Skin Diseases of the National Institutes of Health [NIH K08AR065577, R01AR070116]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.